Company to Discuss Clinical Trials using Menstrual Blood Derived Stem Cells for Treating Cardiovascular Disease SAN DIEGO--(BUSINESS WIRE)-- Medistem announced today Dr. Alan Lewis, the recently appointed CEO of Medistem, will be presenting at the Stem Cells on the Mesa meeting. The company will discuss its ongoing programs at creating effective treatments … [Read more...]

SAN DIEGO, CA -- (Marketwire -09/22/11)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today approval from the FDA to initiate a dose-escalating clinical trial in patients with critical limb ischemia using its Endometrial Regenerative Cell (ERC) stem cell product. This approval puts Medistem in a small list of companies that have Federal permission to … [Read more...]